Presbyopia-mitigating IOL designs are important advances in refractive cataract surgery. It has been a concern for many surgeons and patients if presbyopia-mitigating IOLs should be used in patients with glaucoma. In this video, Daniel Terveen, MD, reviews the visual and patient-reported outcomes from a prospective, controlled, open-label, interventional study of AcrySof IQ Vivity non-diffractive EDOF in cataract patients with mild controlled glaucoma.
Up Next:
Visual Outcomes in Patients with Bilateral Early to Moderate Primary Open-Angle Glaucoma Following Wavefront Shaping Extended-Depth-of-Focus Intraocular Lens Implantation
Mercé Guarro, MD
Visual Outcomes Following Implantation of a Non-Diffractive Extended Vision IOL in Patients with Early Macular Degeneration
Shail Vasavada, DO
A Prospective Study of the Bilateral Implantation af an Extended Depth of Focus Intraocular Lens in Patients Undergoing Phacoemulsification in One Eye and Phacovitrectomy for Epiretinal Membrane in the Fellow Eye
Laura Sararols, MD
